Combination treatment with oncolytic Vaccinia virus and cyclophosphamide results in synergistic antitumor effects in human lung adenocarcinoma bearing mice

BACKGROUND: The capacity of the recombinant Vaccinia virus GLV-1h68 as a single agent to efficiently treat different human or canine cancers has been shown in several preclinical studies. Currently, its human safety and efficacy are investigated in phase I/II clinical trials. In this study we set ou...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Hofmann, Elisabeth, Weibel, Stephanie, Szalay, Aladar A
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2014
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4105246/
https://ncbi.nlm.nih.gov/pubmed/25030093
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-12-197
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi